比较离子霉素与A23187在受精失败或受精受损风险患者中行人工卵母细胞激活的效果
这项单中心7年回顾性队列研究纳入157对夫妇、171个ICSI-AOA周期,比较10 µmol/l离子霉素与商品化A23187的胚胎学与临床结局;离子霉素组在全部三个亚组的受精率均显著更高,但第3天优质胚胎率、临床妊娠率、着床率、活产率及累积活产率两组无显著差异,共获64例活产、72名健康婴儿。
要点
- 离子霉素组受精率在全部三个亚组均显著高于A23187组。
- 低受精组离子霉素第3天卵裂率显著更高,另两组无显著差异。
- 两组第3天优质胚胎率、临床妊娠率、着床率、活产率及累积活产率均无显著差异。
核心结论
- 对于受精失败或受精受损风险患者,10 µmol/l离子霉素行AOA在改善卵母细胞激活方面可能比商品化A23187更有效,尤其在精子相关缺陷病例中。
研究设计与样本
- 单中心、为期7年的回顾性队列研究,纳入157对夫妇,均有ICSI后完全受精失败(TFF,0%)或低受精(<30%)史,或男方患严重少弱畸精子症(OAT)。
- 共行171个ICSI-AOA周期,分别使用10 µmol/l离子霉素或商品化A23187,比较胚胎学与临床结局。
主要发现
- TFF亚组受精率离子霉素组46.9% vs A23187组28.4%(P = 0.002)。
- 低受精亚组受精率离子霉素组67.7% vs A23187组49.2%(P < 0.001)。
- 严重OAT亚组受精率离子霉素组66.4% vs A23187组31.6%(P < 0.001)。
- 低受精组第3天卵裂率离子霉素组显著高于A23187组(P = 0.009),TFF组与严重OAT组均无显著差异(均P > 0.05)。
- 两组第3天优质胚胎率、临床妊娠率、着床率、活产率及累积活产率均无显著差异(均P > 0.05);共64例活产、72名健康婴儿出生。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Do fertilization rates differ between intracytoplasmic sperm injection (ICSI) cycles treated with artificial oocyte activation (AOA) using 10 µmol/l ionomycin or commercial A23187 in women at risk of failed or impaired fertilization? DESIGN: This single-centre, 7-year retrospective cohort study included 157 couples with a history of total fertilization failure (TFF, 0%) or low fertilization (<30%) after ICSI, or with severe oligo-astheno-teratozoospermia (OAT) in the male partner. Couples and underwent 171 ICSI-AOA cycles using either 10 µmol/l ionomycin or commercial A23187. The embryological and clinical outcomes were compared. RESULTS: Fertilization rates in the ionomycin group were significantly higher than those in the A23187 group for all three subgroups (TFF, 46.9% versus 28.4%, P = 0.002; low fertilization, 67.7% versus 49.2%, P < 0.001; severe OAT, 66.4% versus 31.6%, P < 0.001). AOA with ionomycin significantly increased the day 3 cleavage rate (P = 0.009) when compared with A23187 in the low fertilization group, but not in the TFF or severe OAT group (both P > 0.05). The rates of day 3 good-quality embryos, clinical pregnancy, implantation and live birth, and the cumulative live birth, did not differ between the two groups (all P > 0.05). A total of 64 live births resulted in 72 healthy babies born. CONCLUSIONS: AOA with 10 µmol/l ionomycin may be more effective than commercial A23187 in improving oocyte activation in patients at risk of failed or impaired fertilization, especially in cases of sperm-related defects.
引用
- Jia L, Chen P, Su W, et al. Artificial oocyte activation with ionomycin compared with A23187 among patients at risk of failed or impaired fertilization. Reprod Biomed Online. 2022. PMID: 36379856. doi:10.1016/j.rbmo.2022.08.105
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。